EAAs
EAAs, licence 80150470: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- NorthStar Nutraceuticals
- NPN or DIN-HM
- 80150470
- Status
- Active licence
- Licence date
- 18 August 2026
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Méthionine Source : L-méthionine | 130.0 mg | Not calculated |
| L-Isoleucine Source : L-isoleucine | 1666.0 mg | Not calculated |
| L-Thréonine Source : L-thréonine | 130.0 mg | Not calculated |
| L-Histidine Source : L-Histidine | 130.0 mg | Not calculated |
| L-Leucine Source : L-Leucine | 3333.0 mg | Not calculated |
| Potassium Source : Citrate de potassium | 68.0 mg | Not calculated |
Non-medicinal ingredients
Sel rose de l'Himalaya, Acide citrique, Sucralose, Glycérol, Albumen liquide de Cocos nucifera (Noix de coco)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 ans | 1.0 Mesures | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A factor in normal growth and development. A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps in bone development. Helps in energy metabolism/(and) tissue formation. Helps in the development and maintenance of bones/(and) teeth. Helps maintain/support (the) normal function of the nervous system. Helps maintain/support normal/healthy nerve function. Helps to maintain/support heart muscle function. Helps to maintain/support normal electrolyte balance. Helps to maintain/support normal muscle function, including the heart muscle. Helps to maintain/support normal muscle function. Helps to maintain/support the body’s ability to metabolize nutrients. Maintains/supports good health. Mineral supplement. Multi-mineral supplement. Source of (a) mineral(s), a factor/factors in normal growth and development. Source of (a) mineral(s), a factor/factors in the maintenance of good health. Source of (a) mineral(s), to support biological functions which play a key role in the maintenance of good health. Source of (an) (essential) amino acid(s) involved in muscle protein synthesis. Source of (an) (non-essential) amino acid(s) involved in muscle protein synthesis. Source of (an) essential amino acid(s) for the maintenance of good health. Source of branched chain amino acids (BCAAs), which are involved in protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80150470
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.